Health Care & Life Sciences » Pharmaceuticals | Inner Mongolia Furui Medical Science Co. Ltd.

Inner Mongolia Furui Medical Science Co. Ltd. | Ownership

Companies that own Inner Mongolia Furui Medical Science Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Huashang Fund Management Co., Ltd.
6,857,176
3.01%
6,857,176
0.42%
12/31/2017
Huatai-PineBridge Fund Management Co., Ltd.
316,500
0.14%
133,100
0.01%
12/31/2017
ICBC Credit Suisse Asset Management Co., Ltd.
299,819
0.13%
299,819
0.01%
12/31/2017
Hwabao WP Fund Management Co., Ltd.
299,619
0.13%
-18,500
0.02%
12/31/2017
GF Fund Management Co., Ltd.
211,376
0.09%
33,300
0%
12/31/2017
Everbright Pramerica Fund Management Co., Ltd.
173,756
0.08%
173,756
0.01%
12/31/2017
Da Cheng Fund Management Co., Ltd.
48,381
0.02%
23,890
0%
12/31/2017
Truvalue Asset Management Co. Ltd.
24,000
0.01%
3,000
0%
06/30/2017
Harvest Fund Management Co., Ltd.
0
0%
-9,400
0%
12/31/2017
Soochow Asset Management Co., Ltd.
0
0%
-19,820
0%
12/31/2017

About Inner Mongolia Furui Medical Science Co.

View Profile
Address
7/F, Building 2, Kunsha Center
Beijing Beijing 100027
China
Employees -
Website http://www.fu-rui.com
Updated 07/08/2019
Inner Mongolia Furui Medical Science Co., Ltd. engages in the provision of liver fibrosis diagnosis and treatment services. It focuses on disease diagnosis, drug treatment, and chronic disease management. Its business includes pharmaceutical production and sales, equipment research and development and sales, and medical services.